IP Library Granted Patent US 10,799,483
Granted Patent B2
US 10,799,483 · App. 15/944,967 · Granted Oct 13, 2020

Use of isoxazoline compounds for treating demodicosis

Inventors: Heike Williams (Offenbach am Main, DE); Anja Regina Heckeroth (Stadecken-Elsheim, DE); Janina Tanzler (Nieder-Olm, DE); Regis Joel Alain Frenais (Meignanne, FR)
Assignee: Intervet Inc.
A61K31/42A61K9/0014A61K9/0019A61K9/0053A61K9/0056A61K9/20A61K31/422
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,799,483
App. No.
15/944,967
Granted
Oct 13, 2020
Kind
B2
Abstract

The present invention relates to methods of treating demodicosis by administering an isoxazoline compound of formula (I)

Claims (37)

1. A Method of treating generalized demodicosis in a dog that had been diagnosed with a generalized canine demodicosis comprising administering a composition comprising an effective amount of an isoxazoline compound of Formula (II)

wherein

R 1a , R 1b , R 1c are independently from each other hydrogen, Cl or CF 3 ,

T=

Y=methyl, halomethyl, halogen, CN, NO 2 , or NH 2 —C═S,

Q=X—NR 3 R 4 ;

X=CH 2 , CH(CH 3 ), CH(CN), CO, or CS,

R 3 =hydrogen;

R 4 =hydrogen, ethyl, methoxymethyl, halomethoxymethyl, ethoxymethyl, haloethoxymethyl, propoxymethyl, methylcarbonyl, ethyl carbonyl, propylcarbonyl, cyclopropylcarbonyl, methoxycarbonyl, methoxymethylcarbonyl, aminocarbonyl, ethylaminocarbonylmethyl, ethylaminocarbonylethyl, dimethoxyethyl, propynylaminocarbonylmethyl, haloethylaminocarbonylmethyl, cyanomethylaminocarbonylmethyl, haloethylaminocarbonylethyl, —CH 2 —C(O)—NH—CH 2 —CF 3 , —CH 2 —C(O)—NH—CH 2 —CH 3 , —CH 2 —CH 2 —CF 3 or —CH 2 —CF 3 ;

or a salt or solvate or N oxide thereof and a pharmaceutically acceptable carrier, wherein the composition is administered once, twice or three times, wherein the treatment results in microscopical cure.

2. The method according to claim 1 comprising a single administration of the isoxazoline compound to the dog.

3. The method according to claim 1 wherein the isoxazoline compound is administered to the dog orally.

4. The method according to claim 1 wherein the isoxazoline compound is administered to the dog topically.

5. The method according to claim 1 wherein the isoxazoline compound is administered to the dog parenterally by injection.

6. The method according to claim 1 , wherein the amount of the isoxazoline compound is effective to reduce the parasite count by 100%.

7. A method of treating generalized demodicosis in a dog that had been diagnosed with a generalized canine demodicosis comprising administering a composition comprising an effective amount of fluralaner or a salt or solvate or N oxide thereof and a pharmaceutically acceptable carrier, wherein the composition is administered once, twice or three times and wherein the treatment results in microscopical cure.

8. The method according to claim 7 comprising a single administration of 10-40 mg/kg bodyweight of fluralaner to the dog.

9. The method according to claim 7 comprising a single administration of the fluralaner to the dog.

10. The method according to claim 7 wherein the fluralaner is administered to the dog orally.

11. The method according to claim 7 wherein the fluralaner is administered to the dog topically.

12. The method according to claim 7 wherein the fluralaner is administered to the dog parenterally by injection.

13. The method according to claim 7 , wherein the amount of the fluralaner is effective to reduce the parasite count by 100%.

14. A method of treating generalized demodicosis in a dog that had been diagnosed with a generalized canine demodicosis comprising administering a composition comprising an effective amount of afoxolaner or a salt or solvate or N oxide thereof and a pharmaceutically acceptable carrier, wherein the composition is administered once, twice or three times and wherein the treatment results in microscopical cure.

15. The method according to claim 14 comprising a double or triple administration of the afoxolaner to the dog.

16. The method according to claim 14 wherein the afoxolaner is administered to the dog orally.

17. The method according to claim 14 wherein the afoxolaner is administered to the dog topically.

18. The method according to claim 14 wherein the afoxolaner is administered to the dog parenterally by injection.

19. A method of treating generalized demodicosis in a dog that had been diagnosed with a generalized canine demodicosis comprising administering a composition comprising an effective amount of sarolaner or a salt or solvate or N oxide thereof and a pharmaceutically acceptable carrier, wherein the composition is administered once, twice or three times and wherein the treatment results in microscopical cure.

20. The method according to claim 19 comprising a double or a triple administration of the sarolaner to the dog.

21. The method according to claim 19 wherein the sarolaner is administered to the dog orally.

22. The method according to claim 19 wherein the sarolaner is administered to the dog topically.

23. The method according to claim 19 wherein the sarolaner is administered to the dog parenterally by injection.

24. A method of treating generalized demodicosis in a dog that had been diagnosed with a generalized canine demodicosis comprising administering a composition comprising an effective amount of lotilaner or a salt or solvate or N oxide thereof and a pharmaceutically acceptable carrier, wherein the composition is administered once, twice or three times and wherein the treatment results in microscopical cure.

25. The method according to claim 24 comprising a double or a triple administration of the lotilaner to the dog.

26. The method according to claim 24 wherein the lotilaner is administered to the dog orally.

27. The method according to claim 24 wherein the lotilaner is administered to the dog topically.

28. The method according to claim 24 wherein the lotilaner is administered to the dog parenterally by injection.

Assignments (1)
CHANGE OF ADDRESS Recorded Sep 26, 2023
From: INTERVET INC.
To: INTERVET INC.
Reel/Frame 065028/0818 →
Priority Claims (1)
EP 14199562 · Dec 22, 2014 · regional
Continuity (2)
Continuation 15537547
Related Publication 20180318265A1 · Nov 8, 2018
Cited By (3)
US 12,304,903 US 12,544,336 US 12,655,138